Grazax Asthma Prevention
Phase of Trial: Phase III
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Allergic rhinoconjunctivitis; Asthma; Grass pollen hypersensitivity
- Focus Registrational; Therapeutic Use
- Acronyms GAP
- Sponsors ALK-Abello
- 07 Jul 2017 Results published in an ALK-Abello media release.
- 30 Jun 2017 According to an ALK-Abello media release, data from the study has been published online in press in The Journal of Allergy and Clinical Immunology.
- 30 Jun 2017 Results published in an ALK-Abello media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History